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1. Introduction
Acute lung injury is one of the common severe clinical
diseases. It refers to the syndrome after alveolar epithelium
and vascular endothelial cells are injured by  severe
trauma, infection and others, the main manifestations
are progressive hypoxemia and respiratory distress,
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acute lung injury’s condition is usually complex, 
serious, rapid, often leads to acute respiratory distress 
syndrome and even mult iple  organ dysfunct ion 
syndrome, have high clinical mortality rate [1,2]. There 
is no effective treatment at present, the hospital usually 
adopts emergency treatment such as primary trauma 
or disease treatment, mechanical ventilation, hormone 
application, etc, clinical effect is not good. The author 
selected 47 patients with acute lung injury from January 
2009 to February in 2014, on the basis of conventional 
emergency treatment measures, applied Tanreqing 
injection to dicuss the clinical effect of Tanreqing 
injection on the treatment of acute lung injury.
2. Materials and methods
2.1. Clinical data
The author selected 47 patients with acute lung injury in
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ABSTRACT Objective: To discuss the clinical effect of Tanreqing injection in 
treatment of acute lung injury. Methods: 47 patients with acute lung injury in our 
hospital from January 2009 to February 2014 are selected and randomly divided into 
two groups. The control group has 24 cases and receives the conventional emergency 
treatment measures, including establishment of intravenous channel, loop support, 
oxygen inhalation, antibiotics application and primary trauma treatment, etc. 
There are 23 cases in experimental group, on the basis of treatment of the control 
group, they are treated with Tanreqing injection. The two groups are compared 
after treatment to study the clinical efficiency, blood gas index, SIRS score and 
the incidence of ARDS. Results: The treatment efficiency of patients with acute 
lung injury in experimental group is significantly higher than the control group (p 
< 0.05). After treatment, the blood gas index such as PO2, PCO2, PO2 / FiO2 and 
others and SIRS score of patient with acute lung injury in both groups are obviously 
improved, and the experimental group is significantly better than the control group 
(p  < 0.05). At the same time, the incidence of ARDS of patients with acute lung 
injury in the experimental group is significantly lower than the control group (p < 
0.05). Conclusion: The use of tanreqing injection during the treatment of acute 
lung injury can effectively improve patients’ ventilation and alleviate symptoms of 
respiratory distress and has good prognosis.
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our hospital from January 2009 to February 2014, and 
these patients were all consistent with the acute lung injury 
diagnostic criteria of severe medical branch of Chinese 
Medical Association [3]. These selected acute lung injury 
patients were divided into two groups by random number: 
there were 24 cases in control group, 15 males and 9 
females. They aged from 20 to 62 years old and the average 
age was (43.2 ± 6.7 mm) years old, APACHE score was 
18.6 ± 5.4. There were 23 cases in experimental group, of 
which 15 cases were male and 8 cases were female. They 
aged from 21 to 65 years old with average of (44.0 ± 7.5 
mm) years old, APACHE score was 18.4 ± 5.7. The two
groups of patients with acute lung injury had no significant
difference in age, sex, APACHE score and other clinical
data (p > 0.05).
2.2. Method
2.2.1. Treatment
The Control group received conventional emergency 
treatment measures, including establishment of intravenous 
channel, loop support, oxygen inhalation, antibiotics 
application and primary trauma treatment. On the basis 
of treatment of the control group, experimental group was 
administrated by intravenous drip of 20 mL of Tanreqing 
injection + 250 mL of 5% glucose injection, once a day, 
treated for 7 days.
2.2.2. Research Methods
The author screened patients with acute lung injury in our 
hospital from January 2009 to February 2014 and found 47 
cases of acute lung injury patients conformed to the study. 
Random method was used to divide them into two groups. 
There were 24 cases in control group, accounting for 51% 
of the total. Conventional emergency treatment measures 
were used, including establishment of intravenous channel, 
loop support, oxygen inhalation, antibiotics application 
and primary trauma treatment, etc. there were 23 cases 
in experimental group, accounting for 49% of the total. 
On the basis of treatment of the control group, they were 
treated with Tanreqing injection. The clinical effect of 
two groups was compared after treatment. The blood gas 
index, SIRS score and the incidence of ARDS were mainly 
compared.
2.3. Observation indicators
The blood gas indexes such as PO2, PCO2, PO2 / FiO2 and 
others of patients with acute lung injury were determined 
and SIRS score was evaluated before and after treatment. 
At the same time, cases of acute lung injury patients with 
invasive mechanical ventilation and acute respiratory 
distress syndrome (ARDS) were recorded.
2.4. Statistical processing
Using SPSS 12.0 software to do statistical processing, 
measurement data were treated by t  test, count data were 
treated by chi-square test, There were statistical differences 
due to p < 0.05.
3. Results
3.1. Comparition of clinical effective rate between two
groups
In acute lung injury patients of the control group, 3 cases
turned to invasive mechanical ventilation treatment, the
clinical effective rate was 87.5% (21/24).
   In acute lung injury patients of the experimental group, 
1 case turned to invasive mechanical ventilation treatment, 
the clinical effective rate was 95.6% (22/23).
 The clinical effective rate of the experimental group was 
significantly higher than the control group (p < 0.05). See Table 1.
Table 1. Comparition of clinical effective rate between two 
groups.
Group Case
Case of invasive 
mechanical ventilation
Effective rate (%)
control 
group
24 3 87.5
experimental 
group
23 1 95.6 *
*Compared with the control group, p < 0.05.
3.2. Comparison of blood gas indexes and SIRS score of 
two groups between before and after treatment
Before treatment, the control group and experimental 
group had no statistical difference in blood gas indexes 
such as PO2, PCO2, PO2 / FiO2 and others and SIRS score (p 
> 0.05). After treatment, the above indexes were obviously
Table 2. Comparison of blood gas indexes of two groups between before and after treatment.
Laboratory index
Control group Experimental group
Before treatment After treatment Before treatment After treatment
PO2 (mmHg) 78.1 ± 6.5 90.4 ± 8.5 * 78.6 ± 7.0 105.9 ± 10.3 *
PCO2 (mmHg) 28.3 ± 3.1 34.2 ± 3.4 * 28.7 ± 2.8 40.2 ± 3.8 *
PO2/FiO2 (mmHg) 221.6 ± 20.3 294.6 ± 42.8 * 222.1 ± 19.7 354.8 ± 50.2 *
SIRS score 3.8 ± 1.5 2.3 ± 0.9 * 3.9 ± 1.3 1.2 ± 0.5 *
*compared with before treatment, p < 0.05; compared with control group, p < 0.05.
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improved in both groups and the experimental group was 
significantly better than the control group (p < 0.05). See 
Table 2.
3.3. Comparison of the occurrence rate of ARDS 
between two groups
The occurrence rate of ARDS in the control group was 
41.2%, while the experimental patient was 19.5%. Thus, 
the occurrence rate of ARDS in experimental group was 
significantly lower than the control group (p < 0.05). See 
Table 3.
Table 3. Comparison of the occurrence rate of ARDS between 
two groups.
Group Case ARD Case
Occurrence rate 
(%)
Control group 24 10 41.6
Experimental group 23 5 21.7 *
*Compared with control group, p < 0.05.
4. Discussion
In recent years, with the continuous development and
progress of our economy and traffic, the amount of trauma
patients is showing an increasing trend year by year. Severe
trauma has become to be one of main causes of acute lung
injury. When severe trauma occurs, it gives huge impact
force to chest wall, causing chest cavity to become narrow,
intrathoracic pressure to rise suddenly, compression of
lung parenchyma, leading to hemorrhage and edema. Then
the external force disappear, intrathoracic pressure gets fast
recovery, the generation of negative pressure causes lung
parenchyma damage again, bleeding is aggravated. Existing
research showed that [4] the pathogenesis of acute lung
injury is excessive inflammatory response of the whole
body. Severe trauma causes the release of IL-6, IL-8, TNF
alpha and other inflammatory mediators, at the same time,
it will activate the macrophage system, The inflammatory
cytokines release further activate the neutrophils and
others, resulting in accumulation of oxygen free radicals
and arachidonic acid to form a cascade amplification effect,
eventually leading to excessive systemic inflammatory
response, the body’s inflammatory steady-state becomes
unbalanced, acute lung injury occurs.
   The purpose of emergency treatment of acute lung injury 
is to prevent the progress of condition to acute respiratory 
distress syndrome. The key is to effectively control the body 
excessive inflammation in early stage. Tanreqing injection 
is a new kind of Chinese patent medicine. The main 
ingredients are skullcap, cornugorais and honeysuckle, 
etc. Modern pharmacology study proves that [5,6] the 
flavonoids in skullcap has significant anti-inflammatory 
and anti-allergy effect. Meanwhile, the keratin of 
cornugorais contains a variety of active amino acid, which 
can effectively relax bronchial and has smooth wheezing 
expectorant effect. In addition, the chlorogenic acid and 
isochlorogenic acid composition in floslonicerae has the 
function of sedative antipyretic, immunity adjustment and 
anti-pathogenic microorganism. The Tanreqing injection 
applied in acute lung injury can effectively protect alveolar 
endothelial cells, promote restoration of the damaged cells, 
and improve the function of alveolar ventilation.
   The study showed that the treatment efficiency of 
experimental group was significantly higher than the 
control group (p < 0.05). After treatment, the control group 
and experimental group’s blood gas indexes such as PO2, 
PCO2, PO2 / FiO2and others and SIRS score were obviously 
improved, and the experimental group was significantly 
better than the control group (p < 0.05). At the same time, 
the occurrence rate of ARDS in the experimental group 
was also significantly lower than the control group (p  < 
0.05).
   Above all, Tanreqing injection for treatment of acute lung 
injury is clinically effective it can effectively improve the 
ventilation conditions, alleviate symptoms of respiratory 
distress and have clinical popularization using value.
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